---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-081023"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2024-09-23T23:59:59+00:00"
generated_at: "2026-05-31T02:32:26.058566+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CFO Charles R. Carter to depart CERo Therapeutics; successor search underway

## Summary
- CFO Charles R. Carter informed Board he will leave on Sept 30, 2024 for a role at another public company.
- Board has commenced a search for a new CFO; Carter will assist with transition for a brief period.
- Carter's departure is effective Sept 30, 2024; no successor named yet.

## SEC filing metadata
- accession: 0001213900-24-081023
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2024-09-23T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390024081023/0001213900-24-081023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390024081023/ea021534602-8k_cerothera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-081023
- JSON: https://secwatch.observer/filing/0001213900-24-081023.json
- Plain text: https://secwatch.observer/filing/0001213900-24-081023.txt

## Key facts
- Executive change
  Charles R. Carter resigned as Chief Financial Officer at CERO THERAPEUTICS HOLDINGS, INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On September 17, 2024, the Chief Financial Officer of CERo Therapeutics Holdings, Inc. (the “ Company ”), Charles R. Carter, informed the Board of Directors of the Company (the “ Board ”) that he expects to accept a new position with another publicly-traded company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1870404/000121390024081023/0001213900-24-081023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.